• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[心内膜炎和心脏起搏器的多因素预防。关于207例患者的前瞻性研究]

[Multifactor prevention of endocarditis and cardiac pacemakers. A prospective study apropos of 207 patients].

作者信息

Graux P, Lequeuche B, Guyomar Y, Carlioz R, Delfaut P, Beaugeard D, Noël A M, Dutoit A

机构信息

Service de Cardiologie, CH Saint-Philibert, Lomme.

出版信息

Ann Cardiol Angeiol (Paris). 1996 Mar;45(3):113-8.

PMID:8762912
Abstract

Infections after cardiac pacemaker implantation are rare (0.13 to 12.6%) but potentially severe complications. Staphylococcus is the genus most frequently isolated (72 to 100% of cases). The use of systematic prophylactic antibiotics remains controversial. From November 1991 to October 1993, 207 consecutive patients were submitted to a series of measures designed to reduce the risk of infection: a) intravenous bolus injection of Cefamindole, 15 minutes before implantation, b) cutaneous disinfection with iodinated polyvindone, c) injection of an ampoule of rifampin before closure of the pacemaker in the pouch, d) absence of drainage system. Patients were predominantly female (60.9%), with a mean age of 77 +/- 10 years, frequently suffering from heart disease (53.8%). The indication for implantation was atrioventricular block (39.7%), carotid sinus syndrome (27.5%), atrial arrhythmia (27.5%), resection of the node-His tract (5.3%). This procedure corresponded to the first implantation in 88.4% or replacement of a previous pacemaker in 11.6% of cases and the pacing mode was single-chamber (38.4% or replacement of a previous pacemaker in 11.6% of cases and the pacing mode was single-chamber (38.7%), or double chamber (61.3%). The mean duration of the procedure was 51.5 min +/- 30 min. The mean follow-up was 12.7 +/- 5 months. The overall mortality was 14% (11 cases of cardiac failure, 6 sudden deaths, 4 cerebrovascular accidents, 4 cases of pneumonia, 4 neoplasms). Only one infectious problem (endocarditis, i.e. 0.48%) was observed.

摘要

心脏起搏器植入术后感染虽罕见(发生率为0.13%至12.6%),却是潜在的严重并发症。葡萄球菌是最常分离出的菌属(占病例的72%至100%)。系统性预防性使用抗生素仍存在争议。1991年11月至1993年10月,连续207例患者接受了一系列旨在降低感染风险的措施:a)植入前15分钟静脉推注头孢孟多;b)用聚维酮碘进行皮肤消毒;c)在起搏器囊袋关闭前注射一支利福平;d)不设引流系统。患者以女性为主(占60.9%),平均年龄77±10岁,常患有心脏病(占53.8%)。植入指征为房室传导阻滞(占39.7%)、颈动脉窦综合征(占27.5%)、房性心律失常(占27.5%)、结希氏束切除(占5.3%)。该手术在88.4%的病例中为首次植入,在11.6%的病例中为更换先前的起搏器,起搏模式为单腔(占38.7%)或双腔(占61.3%)。手术平均时长为51.5分钟±30分钟。平均随访时间为12.7±5个月。总死亡率为14%(11例心力衰竭、6例猝死、4例脑血管意外、4例肺炎、4例肿瘤)。仅观察到1例感染问题(心内膜炎,即0.48%)。

相似文献

1
[Multifactor prevention of endocarditis and cardiac pacemakers. A prospective study apropos of 207 patients].[心内膜炎和心脏起搏器的多因素预防。关于207例患者的前瞻性研究]
Ann Cardiol Angeiol (Paris). 1996 Mar;45(3):113-8.
2
Increased base rate of atrial pacing for prevention of atrial fibrillation after implantation of a dual-chamber pacemaker: insights from the Atrial Overdrive Pacing Study.双腔起搏器植入后提高心房起搏基础频率预防心房颤动:来自心房超速起搏研究的见解
Europace. 2007 Nov;9(11):1024-30. doi: 10.1093/europace/eum170. Epub 2007 Oct 3.
3
Management of far-field R wave sensing for the avoidance of inappropriate mode switch in dual chamber pacemakers: results of the FFS-test study.双腔起搏器中用于避免不适当模式转换的远场R波感知管理:FFS测试研究结果
J Cardiovasc Electrophysiol. 2006 Sep;17(9):992-7. doi: 10.1111/j.1540-8167.2006.00545.x.
4
Economic and health consequences of managing bradycardia with dual-chamber compared to single-chamber ventricular pacemakers in Italy.在意大利,与单腔心室起搏器相比,使用双腔起搏器治疗心动过缓的经济和健康后果。
J Cardiovasc Med (Hagerstown). 2008 Jan;9(1):43-50. doi: 10.2459/JCM.0b013e328013cd28.
5
Long-term hemodynamic benefit of atrial synchronization with A2A2D or A2A2T pacing in sinus node syndrome after orthotopic heart transplantation.原位心脏移植术后窦房结综合征患者采用A2A2D或A2A2T起搏进行心房同步化的长期血流动力学益处。
J Heart Lung Transplant. 1998 Sep;17(9):906-12.
6
The mode selection trial (MOST) in sinus node dysfunction: design, rationale, and baseline characteristics of the first 1000 patients.窦房结功能障碍的模式选择试验(MOST):前1000例患者的设计、原理及基线特征
Am Heart J. 2000 Oct;140(4):541-51. doi: 10.1067/mhj.2000.109652.
7
Atrial natriuretic peptide for monitoring cardiovascular system performance following pacemaker implantation.心房利钠肽用于监测起搏器植入后的心血管系统功能
Kardiol Pol. 2005 Mar;62(3):202-9; discussion 210.
8
[Endocarditis on cardiac pacemaker endocavitary electrodes. Apropos of 7 cases].[心脏起搏器心腔内电极相关的心内膜炎。附7例报告]
Arch Mal Coeur Vaiss. 1986 Apr;79(4):483-8.
9
Cost-effectiveness of dual-chamber pacemaker therapy: does single lead VDD pacing reduce treatment costs of atrioventricular block?双腔起搏器治疗的成本效益:单导联VDD起搏能否降低房室传导阻滞的治疗成本?
Eur Heart J. 2001 Jan;22(2):174-80. doi: 10.1053/euhj.2000.2126.
10
Single chamber atrial pacing: a realistic option in sinus node disease: a long-term follow-up study of 213 patients.单腔心房起搏:窦房结疾病的一种现实选择:对213例患者的长期随访研究
Pacing Clin Electrophysiol. 2007 Jun;30(6):740-7. doi: 10.1111/j.1540-8159.2007.00744.x.